Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptide
KALRN
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5513046
Aperçu rapide pour Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptide (ABIN5513046)
Antigène
KALRN
(Kalirin, RhoGEF Kinase (KALRN))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- GRKSFDLGSP KPGDETTPQG DSADEKSKKG WGEDEPDEES HTPLPPPMKI
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- KALRN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- KALRN (Kalirin, RhoGEF Kinase (KALRN))
-
Sujet
-
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described.
Alias Symbols: DUO, CHD5, DUET, TRAD, CHDS5, HAPIP, ARHGEF24
Protein Size: 738 -
ID gène
- 8997
-
NCBI Accession
- NM_001024660, NP_001019831
Antigène
-
Vous êtes ici:
